Warner Bros. Discovery closed the prior session at $25.61, a level that sits 17.4% below the $31.00 all-cash deal price agreed to by Vital Skydance. The discount has widened rather than narrowed, driven by a federal judge’s decision to pause the transaction on July 20, shifting the stock toward its status as a high-risk arbitrage play. Trading volume spiked on the news, with 44.2 million shares changing hands on the day of the restraining order. At $25.61, the stock sits near the top of its 52-week range but below its 200-day moving average. Market capitalization sits near $67 billion, reflecting a valuation where fundamentals have become secondary to legal outcomes.
Calculating the Spread and the Delay
The trade here relies on arithmetic rather than earnings. At $25.61 against a $31.00 cash price, the gross spread is $5.39 per share, representing 21% upside on completion. That is an extraordinary spread for a deal that has secured shareholder and Justice Department approval, though the European Commission’s conditional clearance adds a layer of uncertainty.
The ticking fee structure changes the math significantly. Under the merger agreement, additional consideration accrues at $0.00277778 per share per day beyond September 30, 2026. If the transaction runs to the June 1, 2027 outside date, the cumulative addition is approximately $0.678 per share. Vital initially offered a quarterly fee, converting to a daily accrual to signal confidence in speed. That confidence has not aged well.
Related: Blackberry Stock Sees June Rebound
The trade is now running on duration. A 21% return in three months is a 100%-plus annualized trade, while the same return in eleven months is roughly 23% annualized. The market has already adjusted, widening the spread after Vital agreed on July 24 to delay closing until five days after a ruling on the merits or June 1, 2027. This concession eliminates the immediate risk of a preliminary injunction but adds eleven months of waiting.
There is a distinct possibility that the extended timeline erodes the value of the spread. While the $7 billion break fee provides a theoretical floor, investors will naturally discount the price further if they are forced to wait a year for a verdict. The risk is that the “waiting game” becomes the dominant factor, causing the spread to widen beyond the protection of the termination fee.
The Legal Hurdle and the Break Fee
The judge’s language in the July 20 ruling is more adverse than the headlines suggested. US District Judge Araceli Martínez-Olguín wrote that the states’ lawsuit presented compelling evidence that the combined firm would possess substantial market share. She noted that on market share alone, the court could presume the merger is likely to violate antitrust laws.
Related: Shein faces losses ahead of Hong Kong IPO
This phrasing shifts the burden to the merging parties to rebut the presumption. It also means Vital and Warner Bros. will continue to operate as separate companies while the case is adjudicated, undercutting arguments that the transaction is time-sensitive. The California Attorney General filed the complaint alongside eleven other states, alleging the deal violates the Clayton Act.
Despite the legal headwinds, a massive financial safety net remains. If specified regulatory termination criteria are met, Vital must pay Warner Bros. Discovery $7 billion. Against the March share count, that corresponds to approximately $2.79 per share. It represents nearly 24% of WBD’s net debt as of March, a figure that would immediately take leverage below 3.0 times if the fee were triggered.
The market has not fully capitalised this fee. The payment is subject to strict conditions and triggers, and the current litigation is a state action rather than a federal one. However, the asymmetry remains: a block scenario that most investors are pricing as a collapse toward the low $20s carries a $2.79 per share cash offset. That is the floor beneath the position.
Related: Oil prices surge after Houthi attacks on Saudi tankers
The Path Forward and the July 31 Deadline
Both sides are required to submit a joint statement setting out the trial schedule by July 31. That filing is the next real catalyst, determining whether the market faces a three-month wait or an eleven-month one. The difference in timing significantly impacts the annualised return for arbitrageurs.
Vital pushed for a three-day evidentiary hearing in August, arguing that a preliminary injunction would create commercial uncertainty. The states, however, secured a longer timeline, arguing they needed time for discovery. The resulting stipulation cancelled the August 3 preliminary injunction hearing and removed the Writers Guild of America from the suit.
The transaction has now collided with four regulatory regimes with varying results. The Justice Department cleared the deal, and the European Commission cleared it with conditions. The United Kingdom is still considering intervention on media plurality, while the California court has produced the most adverse finding. With no trial date set, the calendar is dominated by the July 31 filing.
Leave a Reply